Domestic:
+91 92 5656 7676
International:
+1 647 893 7323


PARNZOLEIX™ - DSR
Pantoprazole Gastro-resistant 40MG and Domperidone (SR) 30MG Capsules IP
PACKING SIZE / TYPE
10x10 Alu Alu Pack
Summary
PARNZOLEIX™ - DSR CAPSULES is a combination medication designed to manage and relieve symptoms associated with gastroesophageal reflux disease (GERD) and related conditions, such as acid reflux, heartburn, and nausea. Each tablet contains Pantoprazole 40 mg, a proton pump inhibitor that reduces stomach acid, and Domperidone 30 mg, a dopamine antagonist that promotes gastrointestinal motility, alleviating symptoms like bloating and nausea.
Side Effects
Common side effects of PARNZOLEIX™ - DSR CAPSULES may include:
Headache
Dizziness
Diarrhea or constipation
Dry mouth
Stomach discomfort or gas
Fatigue
Severe side effects (rare):
Severe allergic reactions (e.g., rash, itching, swelling)
Unusual changes in heartbeat
Severe abdominal pain
Persistent diarrhea
If any of these severe side effects occur, seek medical attention immediately.
Usage
PARNZOLEIX™ - DSR CAPSULES are commonly prescribed for:
Gastroesophageal Reflux Disease (GERD)
Acid reflux and heartburn
Nausea and vomiting associated with gastric discomfort
Gastric motility disorders
Concerns
Pregnancy: Consult your doctor before using this medication if you are pregnant, as it may not be suitable during pregnancy.
Breastfeeding: The drug is excreted in breast milk; consult a healthcare professional if you are breastfeeding.
Liver Disease: Patients with liver dysfunction should use PARNZOLEIX™ - DSR CAPSULES cautiously, and dose adjustments may be necessary.
Kidney Disease: If you have any kidney issues, talk to your doctor to evaluate the safety and appropriate dose.
When not to use?
PARNZOLEIX™ - DSR CAPSULESshould not be used in the following conditions:
Allergy or hypersensitivity to Pantoprazole, Domperidone, or any of the tablet components.
Severe liver impairment or liver failure.
Gastrointestinal bleeding or obstruction.
Prolonged QT syndrome or heart conditions.
Children under the age of 12 years (unless specifically prescribed by a doctor).
Warnings
Prolonged Use: Prolonged use of Pantoprazole can lead to vitamin B12 deficiency or magnesium deficiency. Regular monitoring is advised.
Cardiac Concerns: Domperidone may affect heart rhythm and should be used cautiously in patients with pre-existing heart conditions.
Interactions: PARNZOLEIX™ - DSR CAPSULES can interact with several other drugs, including anticoagulants, antifungals, and other gastrointestinal medications. Always inform your doctor about all the medications you are taking.
Alcohol: It is recommended to avoid alcohol while using PARNZOLEIX™ - DSR CAPSULES as it may worsen side effects such as dizziness or nausea.
Dosage
Recommended Dose: 1 tablet per day, preferably in the morning before food.
Missed Dose: If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. Do not take double doses to make up for a missed one.
Interactions
PARNZOLEIX™ - DSR CAPSULESmay interact with several other medications, including:
Antacids: Can reduce the effectiveness of Pantoprazole if taken together.
Blood thinners: May interact with warfarin, increasing the risk of bleeding.
Antifungal drugs: Medications like ketoconazole may interfere with Pantoprazole’s absorption.
CNS depressants: Domperidone may enhance the sedative effects of CNS depressants, such as benzodiazepines.
Antibiotics: Antibiotics such as clarithromycin may interact with Pantoprazole.
General Instructions
Always follow your doctor's prescription and do not self-medicate.
Inform your doctor if you are pregnant, breastfeeding, or have any pre-existing medical conditions.
Avoid sudden discontinuation of the medication to prevent a relapse of symptoms.
Keep the tablets stored in a cool, dry place, away from direct sunlight, and out of reach of children.
Other Details
Packaging: PARNZOLEIX™ - DSR CAPSULES are available in strip packaging containing 10 tablets per strip.
Shelf Life: 24 months from the date of manufacturing.
References
Borchard, G. et al. (2006). Clinical Pharmacokinetics of Pantoprazole and Its Therapeutic Application. Therapeutic Drug Monitoring.
Domperidone in Gastrointestinal Motility Disorders: A Review of Clinical Applications. Journal of Clinical Gastroenterology.
Pasternak, G., & Yahalom, G. (2014). Effects of Domperidone in Gastrointestinal Disorders. American Journal of Gastroenterology.
